Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

74.19
Delayed Data
As of 3:59pm ET
 +0.45 / +0.61%
Today’s Change
63.76
Today|||52-Week Range
84.15
+3.60%
Year-to-Date

Today’s Trading

Previous close73.74
Today’s open74.10
Day’s range73.62 - 74.27
Volume10,683,041
Average volume (3 months)8,298,671
Market cap$96.4B
Dividend yield2.80%
Data as of 3:59pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-29.40%
Earnings growth (next 5 years)-5.50%
Revenue growth (last year)-5.37%
P/E ratio7.8
Price/Sales3.21
Price/Book5.11

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+12.65+4.47%
AMGNAmgen-5.00-2.76%
ILMNIllumina Inc+2.45+1.41%
BIVVBioverativ Inc-0.27-0.42%
Data as of 4:14pm ET, 07/26/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$2.12
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts